IDYA: IDEAYA Biosciences, Inc. Stock

by  •  • Comments Off on IDYA: IDEAYA Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,912.69
Enterprise Value ($M) 1,828.31
Book Value ($M) 1,180.42
Book Value / Share 13.48
Price / Book 1.62
NCAV ($M) 624.77
NCAV / Share 7.14
Price / NCAV 3.06

Profitability (mra)
Return on Invested Capital (ROIC) -0.23
Return on Assets (ROA) -0.42
Return on Equity (ROE) -0.44

Liquidity (mrq)
Quick Ratio 14.97
Current Ratio 14.97

Balance Sheet (mrq) ($M)
Current Assets 689.71
Assets 1,124.09
Liabilities 64.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.00
Operating Income -326.98
Net Income -274.48
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -247.58
Cash from Investing -502.56
Cash from Financing 677.55

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Janus Henderson Group Plc
02-05 13G/A BlackRock, Inc.
11-14 13G/A Price T Rowe Associates Inc /md/ 4.80 12.51
11-14 13G/A Biotechnology Value Fund L P 1.70 -59.47
11-12 13G/A Fmr Llc 14.96 54.84
2024-02-14 13G/A Avidity Partners Management LP 2.40 -60.26
2024-02-13 13G/A Logos Global Management LP 2.80 -53.85
2024-02-13 13G Vanguard Group Inc 5.39
2024-02-07 13G/A Adage Capital Partners Gp, L.l.c. 4.54 12.44
2024-02-01 13G/A Canaan X L.p. 2.40 -40.96

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-24 220,391 671,939 32.80
2025-02-21 127,682 733,090 17.42
2025-02-20 151,095 569,717 26.52
2025-02-19 110,998 691,665 16.05

(click for more detail)

Similar Companies
HUMA – Humacyte, Inc. IBRX – ImmunityBio, Inc.
IDXX – IDEXX Laboratories, Inc. IFRX – InflaRx N.V.
IGMS – IGM Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io